SCHEMBL20207090

SCHEMBL20207090

CCc1nc(O)c(=O)[nH]c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.40
▸ KDM4E B2RXH2 4/20 0.38
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ DAO P14920 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ CACNA1B Q00975 1/20 0.32
▸ APBA1 Q02410 1/20 0.32
▸ GRIN2D O15399 1/20 0.31
▸ GRIN3B O60391 1/20 0.31
▸ GRIN1 Q05586 1/20 0.31
▸ GRIN2A Q12879 1/20 0.31
▸ GRIN2B Q13224 1/20 0.31
▸ GRIN2C Q14957 1/20 0.31
▸ GRIN3A Q8TCU5 1/20 0.31
▸ RPA1 P27694 1/20 0.31
▸ TNKS2 Q9H2K2 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20206754 0.73 MAPK1 (0.35) KDM4ECYP1A2CYP2C19DAOALDH1A1
SCHEMBL20206755 0.68 POLB (0.32) POLB
SCHEMBL14734455 0.62 MEN1 (0.34) KDM4EALDH1A1SMN1; SMN2MAPK1KMT2A
SCHEMBL8508802 0.60 HTT (0.43) HTTKDM4ECYP1A2CYP2C19ALDH1A1
SCHEMBL13548267 0.59 GLA (0.45) HTTKDM4EALDH1A1SMN1; SMN2POLB
SCHEMBL19365954 0.59 — —
SCHEMBL4421374 0.59 HTT (0.39) HTTKDM4EALDH1A1USP2POLB
SCHEMBL15427229 0.58 L3MBTL1 (0.51) HTTALDH1A1TNKS2SMN1; SMN2
SCHEMBL17551856 0.58 MAPT (0.50) HTTCYP1A2CYP2C19ALDH1A1POLB
SCHEMBL9621372 0.57 KDM4E (0.32) KDM4EALDH1A1SMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098204-A1 6-MEMBERED URACIL ISOSTERES CV6 THERAPEUTICS (NI) LIMITED (GB) 2018-05-31 — — WO disclosed
Send feedback